Volume 17, Issue suppl_B, March 2015

Exploring a distinct way of cardiovascular disease control and prevention in China: the Chinese Society of Cardiology

• Extract
• View article

Chinese experts recommendation on the monitoring and management of variability in responsiveness to antiplatelet therapy

• Abstract
• View article

Traditional Chinese medication Tongxinluo inhibits inflammatory angiogenesis via Bmx/NF-κB/MAPK pathways

• Abstract
• View article

Optimal- vs. standard-antiplatelet therapy on platelet function and long-term clinical outcomes in patients with high on-treatment platelet reactivity: 2-year outcomes of the multicentre, randomized Optimal-antiPlatelet Therapy (OPT) trial

• Abstract
• View article

QTc interval prolongation predicts the ablation outcome in hypertensive patients with paroxysmal atrial fibrillation

• Abstract
• View article

Gender differences in lipid goal attainment among Chinese patients with coronary heart disease: insights from the DYSlipidemia International Study of China

• Abstract
• View article

Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial

• Abstract
• View article

Clinical outcomes and risk factors of periprocedural myocardial injury after successful percutaneous coronary intervention for chronic total occlusions

• Abstract
• View article

Plasma auto-antibodies to angiotensin II receptors are correlated with blood pressure and inflammatory factors in hypertension patients

• Abstract
• View article